These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 33594717)
1. The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma. Wang J; Aldahamsheh O; Ferrena A; Borjihan H; Singla A; Yaguare S; Singh S; Viscarret V; Tingling J; Zi X; Lo Y; Gorlick R; Zheng D; Schwartz EL; Zhao H; Yang R; Geller DS; Hoang BH Ann N Y Acad Sci; 2021 Apr; 1490(1):90-104. PubMed ID: 33594717 [TBL] [Abstract][Full Text] [Related]
2. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer. Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203 [TBL] [Abstract][Full Text] [Related]
4. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998 [TBL] [Abstract][Full Text] [Related]
5. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382 [TBL] [Abstract][Full Text] [Related]
6. Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age. Zhao H; Bauzon F; Bi E; Yu JJ; Fu H; Lu Z; Cui J; Jeon H; Zang X; Ye BH; Zhu L J Biol Chem; 2015 Feb; 290(9):5797-809. PubMed ID: 25583987 [TBL] [Abstract][Full Text] [Related]
7. SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis. Ferrena A; Wang J; Zhang R; Karadal-Ferrena B; Al-Hardan W; Singh S; Borjihan H; Schwartz EL; Zhao H; Oktay MH; Yang R; Geller DS; Hoang BH; Zheng D Mol Cancer Ther; 2024 Feb; 23(2):223-234. PubMed ID: 37871911 [TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer. Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392 [TBL] [Abstract][Full Text] [Related]
9. Targeted Inhibition of the E3 Ligase SCF Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224 [TBL] [Abstract][Full Text] [Related]
10. Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice. Wang H; Bauzon F; Ji P; Xu X; Sun D; Locker J; Sellers RS; Nakayama K; Nakayama KI; Cobrinik D; Zhu L Nat Genet; 2010 Jan; 42(1):83-8. PubMed ID: 19966802 [TBL] [Abstract][Full Text] [Related]
11. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer. Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183 [TBL] [Abstract][Full Text] [Related]
12. A Skp2 autoinduction loop and restriction point control. Yung Y; Walker JL; Roberts JM; Assoian RK J Cell Biol; 2007 Aug; 178(5):741-7. PubMed ID: 17724117 [TBL] [Abstract][Full Text] [Related]
13. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1. Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337 [TBL] [Abstract][Full Text] [Related]
15. Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation. Sistrunk C; Kim SH; Wang X; Lee SH; Kim Y; Macias E; Rodriguez-Puebla ML Am J Pathol; 2013 May; 182(5):1854-64. PubMed ID: 23474082 [TBL] [Abstract][Full Text] [Related]
16. Sulforaphane down-regulates SKP2 to stabilize p27(KIP1) for inducing antiproliferation in human colon adenocarcinoma cells. Chung YK; Chi-Hung Or R; Lu CH; Ouyang WT; Yang SY; Chang CC J Biosci Bioeng; 2015 Jan; 119(1):35-42. PubMed ID: 25070589 [TBL] [Abstract][Full Text] [Related]
17. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation. Appleman LJ; Chernova I; Li L; Boussiotis VA Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077 [TBL] [Abstract][Full Text] [Related]
18. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition. Gupta P; Zhao H; Hoang B; Schwartz EL Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713 [TBL] [Abstract][Full Text] [Related]
19. Specific small molecule inhibitors of Skp2-mediated p27 degradation. Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596 [TBL] [Abstract][Full Text] [Related]
20. Skp2 regulates G2/M progression in a p53-dependent manner. Hu R; Aplin AE Mol Biol Cell; 2008 Nov; 19(11):4602-10. PubMed ID: 18716061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]